FITCHBURG, Mass., March 23, 2015 /PRNewswire/ -- Micron
Medical, a new division of Micron Products, Inc., a wholly owned
subsidiary of Arrhythmia Research Technology, Inc. (NYSE MKT: HRT),
will showcase its contract manufacturing capabilities and services
designed to help orthopaedic OEMs bring products to market quickly,
efficiently and with high value at a low cost. Micron Medical will
be exhibiting at the AAOS Annual Meeting – Booth 1357 –
March 25 – 27, 2015, at the
Venetian/Sands EXPO, Las Vegas,
Nevada.
"Micron Medical is looking forward to introducing its brand and
capabilities to the orthopaedic surgery community," said
Salvatore Emma, Jr., President and
CEO. "As a medical device contract manufacturer that provides
personalized and fully integrated services, we've built the Micron
Medical brand to focus on producing innovative manufacturing
methodologies that deliver speed, agility and the highest quality –
coupled with personalized service for our original equipment
manufacturer (OEM) customers."
In addition to mass production of orthopaedic implant
components, Micron Medical also has the unique capability to
quickly and routinely produce personalized orthopaedic implant
components that match patient-specific anatomies.
Among the products showcased by Micron Medical at its booth will
be FDA-approved orthopaedic knee implants produced for New Era
Orthopaedics, LLC, with which Micron Medical recently entered into
an exclusive manufacturing agreement.
For more information, visit www.micronmedical.com.
About Micron Medical
Micron Medical, a division of
Micron Products, Inc., a wholly owned subsidiary of Arrhythmia
Research Technology, Inc. (NYSE MKT: HRT), is a diversified
contract manufacturing organization that produces highly
engineered, innovative medical device technologies requiring
precision machining and injection molding. Micron Medical harnesses
its engineering design expertise and reliable, proprietary
manufacturing processes to partner with orthopaedic medical device
OEMs to find opportunities and growth. Through its personalized,
fully integrated approach to medical device contract
manufacturing, Micron Medical offers OEMs responsive, adaptive,
comprehensive and nimble production and processes.
About Arrhythmia Research Technology, Inc.
Arrhythmia
Research Technology, Inc. ("ART"), through its wholly owned
subsidiary, Micron Products, Inc., manufactures components, devices
and equipment for medical, military, law enforcement, industrial
and automotive applications. In addition, ART is a market leader in
the production and sale of silver/silver chloride coated and
conductive resin sensors used as consumable component parts in the
manufacture of integrated disposable electrophysiological
sensors.
For more information about ART or Micron Products, visit their
websites: www.arthrt.com and micronproducts.com
Safe Harbor Statement
Forward-looking statements made
herein are based on current expectations of Arrhythmia Research
Technology, Inc. ("ART"), and its wholly owned subsidiary Micron
Products, Inc. ("Micron" and collectively with ART, "our" or the
"Company") that involve a number of risks and uncertainties and
should not be considered as guarantees of future performance. The
factors that could cause actual results to differ materially
include our ability to retain order volumes from customers who
represent significant proportions of net sales; our ability to
maintain our pricing model, offset higher costs with price
increases and/or decrease our cost of sales; variability of
customer delivery requirements; the level of sales of higher margin
products and services; our ability to renew our credit facility and
manage our level of debt and provisions in the debt agreements
which could make the Company sensitive to the effects of economic
downturns and limit our ability to react to changes in the economy
or our industry; failure to comply with financial and other
covenants in our credit facility; volatility in commodity and
energy prices and our ability to offset higher costs with price
increases; continued availability of supplies or materials used in
manufacturing at competitive prices; variability of customer
delivery requirements; variations in the mix of products sold; and
the amount and timing of investments in capital equipment, sales
and marketing, engineering and information technology
resources. More information about factors that potentially
could affect the Company's financial results is included in the
Company's filings with the Securities and Exchange Commission.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/micron-medical-to-showcase-new-brand-contract-manufacturing-capabilities-at-worlds-largest-meeting-of-orthopaedic-surgeons-and-allied-professions-300054313.html
SOURCE Micron Medical, a division of Micron Products, Inc.